Skip to content

    NOVELIX PHARMACEUTICALS LIMITED

    Overview

    Price

    Market Cap

    ₹112 Cr

    Sector

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly

    Balance Sheet

    Balance Sheet

    ₹ Cr · Annual
    Line itemFY16FY17FY18FY19FY20FY21FY22FY23
    LiabilitiesEquity Capital88888888
    Reserves33333-1-1-1
    Borrowings01111001
    Other Liabilities11112310
    Total Liabilities13141413141098
    AssetsFixed Assets12222222
    CWIP00000000
    Investments20100000
    Other Assets1011111112866
    Total Assets13141413141098

    Cash Flow

    Cash Flow

    ₹ Cr · Annual
    Line itemFY15FY16FY17FY18FY19FY20FY21FY22
    ActivitiesCash from Operating02-20-1122
    Cash from Investing-1-10-1000-1
    Cash from Financing-0010-0-0-10
    SummaryCapital Expenditure
    Free Cash Flow02-30-012-0
    FCF Margin

    Valuation

    Cyclical, with too little history

    This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.

    NOVELIX · CYCLICAL_UNMODELABLE

    Learn to analyse NOVELIX PHARMACEUTICALS LIMITED

    Guides on how to read this kind of business and the numbers that matter.